SCHEMBL18007449

SCHEMBL18007449

COC(=O)/C=C/C(=O)O[C@@H]1C[C@@H](C(=O)n2ccnn2)N(C(=O)c2ccccc2)C1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 4/20 0.36
▸ CTSK P43235 1/20 0.35
▸ TSHR P16473 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ MMP2 P08253 3/20 0.33
▸ ANPEP P15144 1/20 0.32
▸ MAPT P10636 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ PABPC1 P11940 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ ABCB1 P08183 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ HRH3 Q9Y5N1 1/20 0.32
▸ VHL P40337 1/20 0.31
▸ PLA2G1B P04054 1/20 0.31
▸ ATG4B Q9Y4P1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18009451 0.86 MMP2 (0.35) MMP2ANPEPHRH3
SCHEMBL18009292 0.83 PIK3CD (0.41) PIK3CDCTSKTSHRRECQLSMN1; SMN2
SCHEMBL18009339 0.82 PIK3CD (0.32) PIK3CD
SCHEMBL18009294 0.82 MMP2 (0.46) PIK3CDCTSKTSHRRECQLSMN1; SMN2
SCHEMBL18009461 0.81 PIK3CD (0.40) PIK3CDCTSKTSHRRECQLSMN1; SMN2
SCHEMBL18007451 0.79 PIK3CD (0.39) PIK3CDCTSKTSHRRECQLSMN1; SMN2
SCHEMBL18007444 0.79 TSHR (0.41) TSHRRECQLSMN1; SMN2MAPTMEN1
SCHEMBL18009300 0.77 PIK3CD (0.42) PIK3CDCTSKTSHRRECQLSMN1; SMN2
SCHEMBL18009283 0.77 ALDH1A1 (0.40) PIK3CDTSHRRECQLSMN1; SMN2MMP2
SCHEMBL18007448 0.77 MEN1 (0.38) PIK3CDCTSKTSHRRECQLSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016127186-A1 FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE NGUYEN MARK QUANG (US) 2016-08-11 — — WO disclosed
Send feedback